- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01556048
Pilot Study of Behavioral Activation for Prolonged Grief
December 1, 2014 updated by: Anthony Papa
The Institute of Medicine identifies Prolonged Grief (PG) as a critical under-addressed public health problem for which are no empirically supported treatments.
The purpose of this application is to pilot-test Behavioral Activation (BA) therapy for PG.
BA is a well supported, stand alone intervention for depression and recently applied to posttraumatic stress disorder, which reduces rumination and avoidance behaviors that otherwise thwart access to natural rewarding contingencies and resources.
The treatment focuses on promoting stable, active routines, self-care behaviors, enhanced self-efficacy, and reengagement with pleasurable activities and significant social resources.
Rumination, disengagement, and low self-efficacy are defining features of PG.
Further, in response to loss of intimates, the key factors that differentiate resilient people from those that have difficulties adapting is the maintenance or fast resumption of social and occupational functioning.
Thus, the main hypothesis of this study is that BA for PG will result in clinically significant reductions in rumination and functional disengagement.
This is a preliminary small-scale pilot assessment of potential efficacy and feasibility of completing a large scale study of BA for PG.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nevada
-
Reno, Nevada, United States, 89557
- University of Nevada, Reno
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- meet criteria for Prolonged Grief Disorder
- must be 21 years old or older
- if taking psychotropic medication, must have been on a stable dose for three or more months prior to study entry
Exclusion Criteria:
- presence of active suicidal or homicidal ideation
- a history of psychotic symptoms
- current participation in psychosocial treatment focused on grief symptoms
- active substance abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IMMEDIATE START GROUP
Randomized to participate in Behavioral Activation for pathological grief starting at Week 1 of entry into the study
|
Behavioral Activation for Major Depressive Disorder (BA; Martell, Addis, & Jacobson, 2001) is based on behavioral theories of depression, which posit that psychopathology occurs when active, goal-directed behavioral repertoires have been either unreinforced or punished.
These aversive consequences tend to reinforce escape and avoidance behavior, such as passively ruminating on unmet needs and/or deprivations, rather than actively engaging the environment.
BA employs operant conditioning principles to increase active, goal-directed behavioral strategies and decrease passive or avoidant behavioral strategies to help people engage with and obtain adequate reinforcement from their environment.
Use of BA was based research suggesting that disengagement/avoidance is related to prolonged pathology after loss
|
|
Placebo Comparator: DELAY START GROUP
Randomized to participate in Behavioral Activation for pathological grief starting at Week 12 of entry into the study
|
Behavioral Activation for Major Depressive Disorder (BA; Martell, Addis, & Jacobson, 2001) is based on behavioral theories of depression, which posit that psychopathology occurs when active, goal-directed behavioral repertoires have been either unreinforced or punished.
These aversive consequences tend to reinforce escape and avoidance behavior, such as passively ruminating on unmet needs and/or deprivations, rather than actively engaging the environment.
BA employs operant conditioning principles to increase active, goal-directed behavioral strategies and decrease passive or avoidant behavioral strategies to help people engage with and obtain adequate reinforcement from their environment.
Use of BA was based research suggesting that disengagement/avoidance is related to prolonged pathology after loss
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in grief symptoms at weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
Inventory of Complicated Grief-Revised
|
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
|
Change from Baseline in PTSD symptoms at weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
PTSD Checklist-Specific
|
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
|
Change from Baseline in symptoms of Major Depressive Disorder at Weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
Depression Anxiety Stress Scales
|
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in levels of rumination at Weeks 12, 24, and 36 post randomization
Time Frame: Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
Ruminative Response Scale
|
Assessments occurring in Weeks 1 (Baseline), 12, 24, and 36 post randomization
|
|
Therapy credibility and client expectancy for improvement after treatment
Time Frame: Assessments occurring post-treatment (12 weeks for immediate start group, 24 weeks for delay start group)
|
Credibility/ Expectancy Questionnaire
|
Assessments occurring post-treatment (12 weeks for immediate start group, 24 weeks for delay start group)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Antony Papa, Ph.D., University of Nevada, Reno
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
March 12, 2012
First Submitted That Met QC Criteria
March 14, 2012
First Posted (Estimate)
March 16, 2012
Study Record Updates
Last Update Posted (Estimate)
December 2, 2014
Last Update Submitted That Met QC Criteria
December 1, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SA08/09-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Gang WangWest China Hospital; The First Hospital of Hebei Medical University; Tianjin... and other collaboratorsRecruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderChina
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Unity Health TorontoUniversity of Toronto; Toronto Metropolitan UniversityRecruitingMajor Depressive Disorder (MDD) | Major Depressive Episode | Treatment-Resistant Major Depressive DisorderCanada
Clinical Trials on Behavioral Activation
-
New York State Psychiatric InstituteCallen-Lorde Community Health CenterCompletedHIV Infection | FatigueUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Recruiting
-
Stanford UniversityCompletedDepression | Major Depressive Disorder | MDDUnited States
-
Hospital Miguel ServetCompletedMajor Depressive DisorderSpain
-
University of WashingtonNational Institute of Mental Health (NIMH)Completed
-
Central Arkansas Veterans Healthcare SystemNational Center for PTSDWithdrawn
-
Stanford UniversityCompletedDepression | Major Depressive Disorder | MDDUnited States
-
Seinajoki Central HospitalTampere UniversityCompletedAnxiety Disorders | Major Depression | Dual Diagnosis | Substance Related DisordersFinland
-
University of WashingtonNational Institute of Mental Health (NIMH); University of South Florida; Weill...Recruiting
-
Northwestern UniversityCompletedDepression | Anhedonia | Bipolar DisorderUnited States